Lentigo maligna and lentigo maligna melanoma in young patients in Australian tertiary centres

Cheng Huang; Hazel Burke; Richard A Scolyer; Pascale Guitera

doi:10.1093/ced/llad089

Abstract

1 min read

This was a retrospective study of all patients with a diagnosis of lentigo maligna or lentigo maligna melanoma at 50 years of age or younger at the time of their first diagnosis in two Australian tertiary centres. The low recurrence rate in younger patients in this study warrants further investigation. Early diagnosis in young patients is crucial to allow early treatment and lifestyle changes to reduce actinic damage and subsequent development of further melanomas.

Related publications

Article2019

Estimated risk of progression of lentigo maligna to lentigo maligna melanoma

Scott W. Menzies, Sakitha Liyanarachchi, E. Osborne Coates, Annika Smith, Claire Cooke‐Yarborough, Serigne Lo, Bruce K. Armstrong, Richard A Scolyer, Pascale Guitera

Article2013

Controversies and evolving concepts in the diagnosis, classification and management of lentigo maligna

Carolyn J Shiau, John F. Thompson, Richard A Scolyer

Article2024

A randomised, controlled, multicentre trial of imiquimod versus radiotherapy for lentigo maligna.

Angela Hong, Serigne Lo, Gerald B. Fogarty, Jonathan R. Stretch, Wei Wang, Pablo Fernández‐Peñas, Richard C. Martin, Matthew Foote, H. Peter Soyer, Jeremy Ruben, Victoria Mar, Lílian Rocha, Christopher Wratten, Helena Collgros, Amanda Pereira, Bruna Melhoranse Gouveia, Richard A Scolyer, Madeleine King, Pascale Guitera

Article2024

Long-term survival of melanoma patients according to primary tumour thickness – an Australian population-based study

Alexander H. R. Varey, Serigne Lo, Gwyn Williams, Anne Ε. Cust, Richard A Scolyer, John F. Thompson

Article2013

Radiotherapy for lentigo maligna: a literature review and recommendations for treatment

Gerald B. Fogarty, Angela Hong, Richard A Scolyer, Enmoore Lin, Lauren E. Haydu, Pascale Guitera, John F. Thompson